Which factors favor extended dual antiplatelet therapy beyond one year in ACS patients with low bleeding risk?

Which factors do you consider when deciding to extend dual antiplatelet therapy (DAPT) beyond one year for ACS patients with low bleeding risk?

• Presence of peripheral artery disease
• Active smoking
• Higher complexity of the index PCI procedure
• Presence of bypass grafts
• Smaller stent diameters (<3 mm)
• Higher coronary artery disease burden
• Use of older-generation stents
• Heavily calcified lesion requiring adjunctive devices for lesion preparation
• Chronic total occlusion lesions
• Bifurcating lesions
• Other